Eucerin

Long before it had its own name on a tube, this brand's defining chemistry was quietly making someone else rich. The emulsifier Isaac Lifschütz developed, granted its patent in the early 1900s, did something no one had reliably managed: it bound water and oil into an ointment base that could sit on a shelf indefinitely without separating. That same base became the technological skeleton of the company's later mass-market face cream, the blockbuster that funded everything else. The dermatologist Paul Gerson Unna recognized its medical value early, advocating the salve base in his clinical writing and helping route it toward medicine rather than vanity.

For decades the products lived behind the pharmacy counter, dispensed on a pharmacist's advice rather than pushed through advertising. Distribution stayed deliberately pharmacy-exclusive so that buyers received qualified guidance, a positioning that shaped the brand's plain, clinical character. The most quietly radical moment arrived in 1950 with an "acid ointment" built on the then-unfamiliar idea that healthy skin sits slightly acidic and benefits from products tuned to that range, an insight that predated mainstream pH-balance marketing by decades. A body-care range followed in the late 1970s.

The portfolio's modern shape came together in the 1990s, when the line moved into targeted facial care for sensitive and damaged skin, including an early antioxidant anti-wrinkle cream that performed well in testing. From there it pushed deeper into genuine clinical territory rather than trend cycles: treatments for eczema and atopic dermatitis, urea-based formulas for very dry and rough skin, and pigment-correcting lines. The result is a catalog that grew by following dermatological problems rather than fashion, with the resolutely utilitarian packaging and understated marketing that have always been part of the deal.

Sources:[1][2][3]